Inventor
BO RAM LEE
Inventor
KR
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
H01Mprimary
H01MProcesses or means, e.g. batteries, for the direct conversion of chemical energy into electrical energy18%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution18%
C01GCompounds containing metals not covered by subclasses c01d or c01f11%
C01PIndexing scheme relating to structural and physical aspects of solid inorganic compounds9%
A61KPreparations for medical, dental or toiletry purposes7%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations5%
B82YSpecific uses or applications of nanostructures4%
C07KPeptides4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for2%
PatentTitleYear
12,551,465Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition202612,532,732Semiconductor device202612,493,048Antibodies binding specifically to NT-proBNP and use thereof202512,419,863Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathy202512,401,021Method for producing positive electrode active material for lithium secondary battery and positive electrode active material for lithium secondary battery produced thereby202512,322,808Conductive agent, electrode including the conductive agent, and secondary battery including the electrode202512,315,153Apparatus and method for predicting biometrics based on fundus image202512,266,800Electrode and secondary battery including the same202512,261,288Method for producing positive electrode active material for lithium secondary battery and positive electrode active material for lithium secondary battery produced thereby202512,249,718Negative electrode and secondary battery including negative electrode202512,115,159Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing GPR119 ligand as active ingredient202412,098,164Non-immunogenic protein nanoparticles with cancer targeting activity using albumin-binding peptide202411,942,632Positive electrode active material particle including core containing lithium cobalt oxide and shell containing composite metal oxide and preparation method thereof202411,611,078Positive electrode active material for lithium secondary battery, comprising lithium cobalt oxide for high voltage, and method for preparing same202311,531,236Liquid crystal display202211,377,367Metal-doped cobalt precursor for preparing positive electrode active material for secondary battery202211,225,743Washing machine and control method thereof202211,183,691Metal-doped positive electrode active material for high voltage202111,165,059Negative electrode active material having high output characteristics and lithium secondary battery including the same2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to LG CHEMICAL LTD (5)· patent assignee history
2021–2026Based in KR· patent location history
2022–2025Patents assigned to LG ENERGY SOLUTION LTD (8)· patent assignee history
2022–2026Patents assigned to SAMSUNG ELECTRONICS CO LTD (2)· patent assignee history
2025–2026Patents assigned to CELLTRION INC (2)· patent assignee history
2025Patents assigned to BIONOTE INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LG ENERGY SOLUTION LTD | 8 | 2022–2025 |
| LG CHEMICAL LTD | 5 | 2021–2024 |
| CELLTRION INC | 2 | 2025–2026 |
| SAMSUNG ELECTRONICS CO LTD | 2 | 2022–2026 |
| BIONOTE INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 19 | 2021–2026 |